ICTD 2019: Patient Stratification Studies, Paris, 20 May
ECRIN and its French scientific partner, the French Clinical Research Infrastructure Network (F-CRIN), are organising a conference in Paris, France on May 20th, 2019 to celebrate International Clinical Trials Day (ICTD).
ICTD 2019 will bring together ECRIN’s internal stakeholders and partners, and additional scientists and policymakers from France, the rest of Europe, and beyond. The meeting objective is to engage participants in discussion on issues related to multinational clinical trials and the clinical research landscape in Europe. ICTD 2019 will focus on challenges raised by patient stratification studies.
The meeting will take place at Luxembourg Palace, 15 rue de Vaugirard, 75006 Paris from 10:30 to 16:30 CET. Participation is free and on a first-come, first-served basis. Registration is mandatory.
Click here to download the draft agenda (overview provided below)
- Mr Gérard Larcher, President of the Senate
- Mr Gilles Bloch, CEO of INSERM
- Jacques Demotes, director general, ECRIN
- Olivier Rascol, coordinator, F-CRIN
- The ‘AETIONOMY’ study: Jean-Christophe Corvol, director of the Clinical Investigations Centre (CIC) of the Brain & Spine Institute (ICM) at Pitié Salpêtrière Hospital (Paris, France)
- Design and statistical methodology in patient stratification programmes: stratification cohort, validation cohort, clinical trials: Rafaël Porcher, Associate Professor of Biostatistics at Paris Descartes University (Paris, France)
- Multimodal data management: clinical, multi-omics and imaging data: Jan-Willem Boiten, programme manager at Lygature (Utrecht, Netherlands)
- Machine learning algorithms for patient stratification: TBD
- Panel discussion
- Multinational cohort integration: Josep Maria Haro, research and teaching director of Fundació Sant Joan de Déu (Barcelona, Spain)
- Reuse of data and biosamples, informed consent and personal data protection challenges Michaela Mayrhofer, senior project manager, BBMRI-ERIC (Graz, Austria)
- Promoting international cooperation in personalised medicine research: International Consortium for Personalised Medicine (ICPerMed)/ Astrid Vincente, head of the Department of Health Promotion and Non-communicable Disease Prevention, principal investigator (Lisbon, Portugal)
- Therapeutic indication based on a multi-omics signature? A regulatory challenge for marketing authorisation: TBD
- The challenges of patient stratification studies and personalised treatments for health technology assessment: Frank Hulstaert, senior researcher, Belgian Health Care Knowledge Centre (KCE) (Brussels, Belgium)
- Panel discussion
In 2005, the International Clinical Trials Day (ICTD) was launched to commemorate the day when James Lind started his famous clinical trial on scurvy in 1747, May 20th, and laid the foundation for modern clinical research.
Celebrated every year on or around May 20th, ICTD is an opportunity for organisations, clinical research professionals, and the public to acknowledge the achievements that result from clinical research and to discuss various trial topics. ECRIN hosts an annual celebration of ICTD, bringing together European and international stakeholders.